Exelixis Access Services
Exelixis Access Services (EASE) includes programs designed to support patients who are prescribed Exelixis oncology drugs Cabometyx or Cometriq (Table).
The EASE programs are drug-specific and provide financial, access, and reimbursement support for eligible patients.
Cabometyx 30-Day Free Trial Program
The 30-Day Free Trial Program provides a free trial to help new Cabometyx patients start treatment quickly, regardless of insurance type. A 30-day additional supply may be available to patients with a payer decision delay of ≥5 days. Restrictions and eligibility rules apply.
EASE Dose Exchange Program
The Dose Exchange program provides a free 15-tablet supply of Cabometyx in the lower dose to help patients who require a dose reduction. restrictions and eligibility rules apply.
EASE Co-Pay Program
Eligible patients with commercial insurance will pay $0 per month for Cabometyx or Cometriq. eligibility restrictions apply.
EASE Patient Assistance Program
Eligible patients who are uninsured or are insured but cannot afford the cost of the medication may receive Cabometyx or Cometriq free of charge.